Although the present study suggests an importance of mTOR pathway activation by secondary bile acids in hepatocarcinogenesis, there are other possible mechanisms that might be involved in the promotion of HCC by accumulated secondary bile acids. The gene discussed is MTOR; the disease is hepatocellular carcinoma.